F ollowing this journal's principled initiative, 1 a process was initiated leading to retraction of a considerable body of studies reported by the German anesthetist Joachim Boldt. As a result, 11 reports addressing the safety and efficacy of hydroxyethyl starch (HES) have been removed from the medical literature 2, 3 as part of a retraction of 88 Boldt publications, in the first instance because of a lack of ethics approval. In addition, besides the first study retracted by Anesthesia & Analgesia, 4 a review of 4 other Boldt studies found that results were probably incorrect and manipulated. 5 An extensive inquiry by the Klinikum Ludwigshafen, Boldt's employer, and the responsible State Medical Association, the Landesärztekammer Rheinland-Pfalz, has been underway for the past year 6 and has reportedly revealed further noncompliance with German medical law, including faults in study design and data classification. 5 An official report of this process is still awaited. Apart from the grievous breaches in ethical issues, readers of Anesthesia & Analgesia are entitled to doubt the veracity of the many Boldt studies claiming to use albumin in cardiac procedures since 1999, when the Klinikum Ludwigshafen has confirmed that no albumin has been used in the hospital since that year. 6 The paucity of evidence supporting the use of HES has been confirmed by a recent systematic review. 7 The collective failure underpinning the Boldt affair also includes the authorities responsible for the approval of these products on the market. The absence of any proactive commentary from them on this matter has been notable. The United States Food and Drug Administration has announced that it will conduct a workshop reviewing the safety of HES sometime in 2012 8 but is awaiting the results of large scale clinical trials, such as the Crystalloid versus Hydroxyethyl Starch Trial. 9 The prudent caution characterizing recent drug withdrawals, such as in the case of Vioxx, 10 appears to be absent for HES. Similarly, the German authority Bundesinstitut fur Arzneimittel und Medixinprodukte's statement that current HES products were approved with minimal clinical data and bridging studies with other HES products 11 appears to be counter to European Union policy requiring new clinical trials for new chemical entities (as the HES manufacturers claim these agents to be). All in all, quiescence appears to have settled on the controversial aspects of HES precipitated by the Boldt scandal and other developments and it is desirable from the clinical perspective that the long ongoing investigations are brought to a speedy conclusion.
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Postoperative Cognitive Deficit Might Relate to Intraoperative Hypotension
To the Editor W e have several questions regarding the recent study by Zhang et al. suggesting that general anesthesia with isoflurane in combination with spinal anesthesia results in a greater percentage of patients with postoperative cognitive decline than those receiving desflurane plus spinal anesthesia or spinal anesthesia alone. 1 First, Zhang et al. do not provide data describing either the extent or duration of hemodynamic change during surgery as well as in the postoperative period. 1 Hypotension is reportedly one of the major predisposing factors for postoperative delirium, 2 and its role in contributing to postoperative cognitive decline is still controversial. 3 Second, rather than using bispectral index as a measure of depth of anesthesia, Zhang et al. should have provided age-adjusted minimum alveolar concentration multiples to ensure that the anesthetic depth in the isoflurane and desflurane groups were comparable. Finally, Zhang et al. should document the fact that the tests of cognition used in this study are valid when administered to Mandarin-speaking but non-English-speaking patients with limited educational levels (8 years).
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